AMGEN INC

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (805)447-1000
CIK: 0000318154
EIN: 953540776
State Location: CA
State of Inc.: DE
Tickers:
  • Nasdaq:AMGN

Form: SCHEDULE 13G

Filing Date: 14 May 2026
Report Date:
Accepted: 14 May 2026 11:55 a.m.
Accession Number: 0001422849-26-000085
Act: 34
File Number: 005-34640
Film Number: 26977694

Documents

Primary Document
Accepted: 14 May 2026 11:55 a.m.